133 related articles for article (PubMed ID: 34075748)
1. Quantitative Proteomics Reveals Knockdown of CD44 Promotes Proliferation and Migration in Claudin-Low MDA-MB-231 and Hs 578T Breast Cancer Cell Lines.
Kim H; Woo J; Dan K; Lee KM; Jin MS; Park IA; Ryu HS; Han D
J Proteome Res; 2021 Jul; 20(7):3720-3733. PubMed ID: 34075748
[TBL] [Abstract][Full Text] [Related]
2. Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells.
Reithmeier A; Panizza E; Krumpel M; Orre LM; Branca RMM; Lehtiö J; Ek-Rylander B; Andersson G
BMC Cancer; 2017 Sep; 17(1):650. PubMed ID: 28915803
[TBL] [Abstract][Full Text] [Related]
3. Glycoproteins in Claudin-Low Breast Cancer Cell Lines Have a Unique Expression Profile.
Yen TY; Bowen S; Yen R; Piryatinska A; Macher BA; Timpe LC
J Proteome Res; 2017 Apr; 16(4):1391-1400. PubMed ID: 28287265
[TBL] [Abstract][Full Text] [Related]
4. The effect of soluble E-selectin on tumor progression and metastasis.
Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
[TBL] [Abstract][Full Text] [Related]
5. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
Liu F; Liu Y; Shen J; Zhang G; Han J
Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
[TBL] [Abstract][Full Text] [Related]
7. Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cells.
Patsialou A; Wang Y; Pignatelli J; Chen X; Entenberg D; Oktay M; Condeelis JS
Oncogene; 2015 May; 34(21):2721-31. PubMed ID: 25088194
[TBL] [Abstract][Full Text] [Related]
8. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
[TBL] [Abstract][Full Text] [Related]
9. Silencing ARHGAP9 correlates with the risk of breast cancer and inhibits the proliferation, migration, and invasion of breast cancer.
Wang T; Ha M
J Cell Biochem; 2018 Sep; 119(9):7747-7756. PubMed ID: 29905031
[TBL] [Abstract][Full Text] [Related]
10. siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468).
Vahidian F; Safarzadeh E; Mohammadi A; Najjary S; Mansoori B; Majidi J; Babaloo Z; Aghanejad A; Shadbad MA; Mokhtarzadeh A; Baradaran B
Mol Biol Rep; 2020 Dec; 47(12):9541-9551. PubMed ID: 33206362
[TBL] [Abstract][Full Text] [Related]
11. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
12. A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44.
Babina IS; McSherry EA; Donatello S; Hill AD; Hopkins AM
Breast Cancer Res; 2014 Feb; 16(1):R19. PubMed ID: 24512624
[TBL] [Abstract][Full Text] [Related]
13. CD44 targets Na(+)/H(+) exchanger 1 to mediate MDA-MB-231 cells' metastasis via the regulation of ERK1/2.
Chang G; Wang J; Zhang H; Zhang Y; Wang C; Xu H; Zhang H; Lin Y; Ma L; Li Q; Pang T
Br J Cancer; 2014 Feb; 110(4):916-27. PubMed ID: 24434427
[TBL] [Abstract][Full Text] [Related]
14. Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo.
Zhang J; Li K; Zhang Y; Lu R; Wu S; Tang J; Xia Y; Sun J
BMC Cancer; 2019 Jun; 19(1):555. PubMed ID: 31182056
[TBL] [Abstract][Full Text] [Related]
15. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
Calaf GM; Ponce-Cusi R; Abarca-Quinones J
Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway.
Yang Y; Cheon S; Jung MK; Song SB; Kim D; Kim HJ; Park H; Bang SI; Cho D
Biochem Biophys Res Commun; 2015 Apr; 459(3):379-86. PubMed ID: 25727011
[TBL] [Abstract][Full Text] [Related]
17. NF-κB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression.
Smith SM; Lyu YL; Cai L
PLoS One; 2014; 9(9):e106966. PubMed ID: 25184276
[TBL] [Abstract][Full Text] [Related]
18. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.
Guo JY; Chiu CH; Wang MJ; Li FA; Chen JY
J Biomed Sci; 2020 Jan; 27(1):2. PubMed ID: 31898491
[TBL] [Abstract][Full Text] [Related]
19. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
[TBL] [Abstract][Full Text] [Related]
20. Effects of CD44 siRNA on inhibition, survival, and apoptosis of breast cancer cell lines (MDA-MB-231 and 4T1).
Dehbokri SG; Noorolyai S; Baghbani E; Moghaddamneshat N; Javaheri T; Baradaran B
Mol Biol Rep; 2024 May; 51(1):646. PubMed ID: 38727931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
